These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. New pathologic techniques for diagnosing genitourinary malignancies. Wojno KJ Cancer Treat Res; 1996; 88():41-75. PubMed ID: 9239472 [No Abstract] [Full Text] [Related]
11. Genitourinary Cancer: Updates on Treatments and Their Impact on the Kidney. Orozco Scott P; Deshpande P; Abramson M Semin Nephrol; 2022 Nov; 42(6):151344. PubMed ID: 37172546 [TBL] [Abstract][Full Text] [Related]
12. Potential use of RNA interference as therapeutic strategy in urologic cancer. Green WJ; James PA; Ratan HL Urology; 2011 Sep; 78(3):500-4. PubMed ID: 21741681 [No Abstract] [Full Text] [Related]
13. Future developments and new research in genitourinary cancers. Perspectives. Alexander RB; Coffey DS Cancer; 1987 Aug; 60(3 Suppl):686-90. PubMed ID: 3496147 [TBL] [Abstract][Full Text] [Related]
14. Biologic tools to personalize treatment in genitourinary cancers. Bracarda S; Sisani M; Del Buono S; Ishiwa O; Montagnani F; Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e42-8. PubMed ID: 21232974 [TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid lesions of the urogenital tract. Reuter VE Semin Diagn Pathol; 1993 May; 10(2):188-201. PubMed ID: 8367626 [TBL] [Abstract][Full Text] [Related]
20. A medical oncologist's perspective on the treatment of patients with genitourinary malignancies. Sternberg CN Urol Oncol; 2009; 27(2):122-5. PubMed ID: 19285223 [No Abstract] [Full Text] [Related] [Next] [New Search]